- Home
- NPKI vs CRMD Comparison
NPKI vs CRMD Comparison
Compare NPKI & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NPKI
- CRMD
- Stock Information
- Founded
- NPKI 1932
- CRMD 2006
- Country
- NPKI United States
- CRMD United States
- Employees
- NPKI N/A
- CRMD N/A
- Industry
- NPKI Metal Fabrications
- CRMD Biotechnology: Pharmaceutical Preparations
- Sector
- NPKI Industrials
- CRMD Health Care
- Exchange
- NPKI Nasdaq
- CRMD Nasdaq
- Market Cap
- NPKI 665.2M
- CRMD 738.4M
- IPO Year
- NPKI N/A
- CRMD 2010
- Fundamental
- Price
- NPKI $7.54
- CRMD $12.30
- Analyst Decision
- NPKI
- CRMD Strong Buy
- Analyst Count
- NPKI 0
- CRMD 6
- Target Price
- NPKI N/A
- CRMD $15.67
- AVG Volume (30 Days)
- NPKI 435.1K
- CRMD 1.4M
- Earning Date
- NPKI 02-19-2025
- CRMD 03-11-2025
- Dividend Yield
- NPKI N/A
- CRMD N/A
- EPS Growth
- NPKI N/A
- CRMD N/A
- EPS
- NPKI N/A
- CRMD N/A
- Revenue
- NPKI $748,372,000.00
- CRMD $12,262,234.00
- Revenue This Year
- NPKI N/A
- CRMD N/A
- Revenue Next Year
- NPKI N/A
- CRMD $246.41
- P/E Ratio
- NPKI $19.97
- CRMD N/A
- Revenue Growth
- NPKI 93.70
- CRMD 41184.20
- 52 Week Low
- NPKI $5.61
- CRMD $2.89
- 52 Week High
- NPKI $8.65
- CRMD $13.85
- Technical
- Relative Strength Index (RSI)
- NPKI N/A
- CRMD 68.48
- Support Level
- NPKI N/A
- CRMD $11.74
- Resistance Level
- NPKI N/A
- CRMD $13.09
- Average True Range (ATR)
- NPKI 0.00
- CRMD 0.72
- MACD
- NPKI 0.00
- CRMD 0.37
- Stochastic Oscillator
- NPKI 0.00
- CRMD 85.09
About NPKI NPK International Inc. Common Stock
NPK International Inc Formerly Newpark Resources Inc is a diversified supplier providing environmentally-sensitive products, as well as rentals and services to customers across multiple industries. The company has two operating segments: Industrial Solutions and Fluids Systems. Fluids Systems segment which generates the majority of the revenue, provides drilling, completion, and stimulation fluids products and related technical services to customers for oil, natural gas, and geothermal projects. Geographically, the company derives majority of its revenue from the United States and also has its presence in Canada, EMEA, Latin America, and Asia Pacific regions.
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets.